Combining nonsteroidal anti-inflammatory drugs with selective serotonin reuptake inhibitors increased the risk of upper gastrointestinal bleeding by up to 190% beyond the baseline risk found for...
The tumor necrosis factor blocker adalimumab is now approved for treating children with Crohn’s disease, down to age 6 years, AbbVie, the manufacturer, announced on Sept. 25.
The approved...
Patients who underwent laparoscopic total mesorectal excision with coloanal anastomosis for rectal cancer had similar rates of mortality and morbidity, regardless of whether the extraction was...
Patients who develop infectious complications after undergoing curative surgery for colorectal cancer face a significantly increased risk of death, results from a large retrospective study...
WASHINGTON – A rationally designed microbiome-based pill successfully eradicated recurrent Clostridium difficile infection in 29 of 30 patients in an <link...
WASHINGTON – Early studies show that a new, combined antiviral regimen seems to suppress hepatitis C viremia while keeping HIV viremia stable in coinfected patients.
Dr. Joseph Eron presented phase...
WASHINGTON – Two studies of men having sex with men suggest that hepatitis C transmission in that group might be on the cusp of a big increase, in part because of risky behavior such as unprotected...
Serious liver injury from herbal and dietary supplements – including those used by bodybuilders – has risen significantly over the past decade.
According to findings from a review, herbal...
Serious liver injury from herbal and dietary supplements – including those used by bodybuilders – has risen significantly over the past decade.
According to findings from a review, herbal...
WASHINGTON – A single-use, self-administered anal insert made of soft silicone was effective and safe in reducing episodes of accidental bowel leakage, in a multi-center, prospective open-label...
